I listen to my clients to understand their needs, gain insight on opportunities they see within their industry, connect with what inspires them about their business and then collaboratively work to articulate the value of their business to the market in order to drive a successful outcome.
Moyo provides mergers and acquisitions (M&A) advisory to leading private equity clients, founder-owned and publicly-held healthcare companies across a variety of sectors, including technology, pharmaceutical services, life sciences, provider-based services and facility-based services, among others.
Moyo works to understand the nature of his clients’ businesses in order to best support their needs as a trusted advisor while directly impacting the progressive transformation and efficiencies within the healthcare space.
Moyo began his career as a systems engineer at Motorola before transitioning into the finance industry with Ernst & Young within the transaction real estate group. He then pivoted to M&A at Stout and Houlihan Lokey prior to joining Lincoln.
Moyo earned a Master of Business Administration from Northwestern University, a Master of Science in finance from DePaul University and a Bachelor of Science in computer engineering from the University of Oklahoma.
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Lincoln International advised EverVet Partners, a portfolio company of Tailwind Capital, on receiving a significant investment from Freeman Spogli & Co.
Lincoln International has advised All About Children on its sale to Partou, a portfolio company of Waterland Private Equity
Lincoln International advised SEKISUI CHEMICAL on the sale of SEKISUI XENOTECH to BioIVT, a portfolio company of Linden Capital Partners
Related Perspectives in Healthcare
In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners
Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More
In Q3 2020, Lincoln International introduced Lincoln’s Latest video series. Experts from across industries, services and geographies, share perspectives on current trends, recent observations and future outlooks through this video… Read More
Surging Medical Inflation Fuels Continued Interest in Self-Funding and Cost Containment
During the past 18 months, inflation has accelerated to levels not seen since the early 1980s. The cost of energy, food and other staples has increased rapidly and is expected… Read More
Lincoln International Expands Presence to Southeast, Opening Miami and Atlanta Offices
Continued growth spurs openings in new geographies for both client coverage and talent acquisition Lincoln International announced today that it has expanded its U.S. footprint with the opening of offices… Read More
Meet our Senior Team
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt